India May Have To Wait Longer For Novo Nordisk’s Weight-Loss Drug Wegovy [formavita keto gummies]

India May Have To Wait Longer For Novo Nordisk’s Weight-Loss Drug Wegovy [formavita keto gummies]

| 1h 28m 28s | Video has closed captioning.

#pharma #novonordisk #weightlossmedication #wegovyweightloss #fda Indians may have to wait a while yet for Danish drug maker Novo Nordisk’s blockbuster weight loss drug Wegovy, which is not expected to hit the market this year. Wegovy, a relatively new drug approved by the US Food and Drug Administration (FDA) in June 2021, mimics the body’s GLP-1 hormone to promote a feeling of fullness, aiding those with obesity or overweight in losing weight."Regarding the timeline for launching Wegovy in India, unfortunately, it will not be this year," Karsten Munk Knudsen, Chief Financial Officer (CFO) and Executive Vice President (EVP) of Novo Nordisk’s, told Business Today. His remarks underline the strategic caution exercised by Novo Nordisk as they strive to balance expanding their market footprint with maintaining supply commitments in existing markets. The drug has seen widespread adoption fairly quickly across the US and several other countries, including Denmark, Norway, Germany, the UK, Iceland, Switzerland, UAE, and Japan. ----------------------- Thank You for watching! Do not forget to Like | Comment | Share ----------------------- About the channel Watch us for the best news and views on business, stock markets, crypto currencies, consumer technology, the world of real estate, bullion, automobiles, start-ups and unicorns and personal finance. Business Today TV will also bring you all you need to know about mutual funds, insurance, loans and pension plans among others. Follow us at: Website: WhatsApp: whatsapp.com/channel/0029Va4Hd309hXFCqY62yD2I Facebook: twitter: Instagram: